Researchers have found a way to increase the effectiveness of a widely used cancer drug, according to a new study. UTMB’s Satish Srivastave said that combining a newly developed drug with the widely used doxorubicin, used to fight numerous kinds of cancers, makes it better suited as colon cancer treatment. Research findings also reported in Health Medicine Network, Texas Medical Center News, Knowridge Science Report, Ecancer, POST Online Media, Health Canal, Medical Xpress, Science Daily, Health Medicine Network, EurekAlert, Public., Newscaf and ScienMag.